Recursion Pharmaceuticals has gained backing from a technology giant, and Peter Ray has joined the company as a senior director.
2 reports, 2 independent
Updated Jul 23
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Recursion Pharmaceuticals has gained backing from a technology giant, and Peter Ray has joined the company as a senior director.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Peter Ray
British architect
Nothing else this week.
-
Recursion (United States)
company in Salt Lake City, United States
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyRecursion Pharmaceuticals (RXRX) Jumps 9.6% Ahead of Q2 Earnings We recently published 10 Resilient Stocks Defying Market Sentiment. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of Monday’s b
- BenzingaWhy Is Recursion Pharma Stock Surging On Monday? In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a